NCT01744756View on ClinicalTrials.gov

Subconjunctival Bevacizumab and Recurrent Pterygium

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

September 30, 2012

Conditions
Recurrent Pterygium
Interventions
DRUG

Bevacizumab

One subconjunctival aplication of Bevacizumabe 0,5ml

Trial Locations (1)

74110120

Instituto de Olhos de Goiania, Goiânia

All Listed Sponsors
lead

Instituto de Olhos de Goiania

OTHER

NCT01744756 - Subconjunctival Bevacizumab and Recurrent Pterygium | Biotech Hunter | Biotech Hunter